Hinge Health, Inc.
HNGE
$40.91
-$1.20-2.85%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 170.73M | 154.21M | 139.10M | 123.83M | 117.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 170.73M | 154.21M | 139.10M | 123.83M | 117.26M |
| Cost of Revenue | 26.55M | 27.97M | 40.44M | 23.59M | 21.17M |
| Gross Profit | 144.17M | 126.24M | 98.66M | 100.23M | 96.09M |
| SG&A Expenses | 84.02M | 100.37M | 398.47M | 63.60M | 52.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 147.00K | 40.00K | 893.00K | 0.00 | -- |
| Total Operating Expenses | 143.47M | 160.30M | 719.77M | 110.69M | 96.35M |
| Operating Income | 27.26M | -6.09M | -580.67M | 13.14M | 20.91M |
| Income Before Tax | 32.22M | -1.64M | -680.15M | 122.31M | 26.17M |
| Income Tax Expenses | 122.00K | 206.00K | -328.00K | 998.00K | -951.00K |
| Earnings from Continuing Operations | 32.10M | -1.84M | -679.83M | 121.31M | 27.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.10M | -1.84M | -679.83M | 121.31M | 27.12M |
| EBIT | 27.26M | -6.09M | -580.67M | 13.14M | 20.91M |
| EBITDA | 27.78M | -5.53M | -580.13M | 13.64M | 21.48M |
| EPS Basic | 0.40 | -0.02 | -13.10 | 7.38 | 1.98 |
| Normalized Basic EPS | 0.25 | -0.01 | -8.19 | 0.69 | 1.19 |
| EPS Diluted | 0.38 | -0.02 | -13.11 | 7.38 | 1.98 |
| Normalized Diluted EPS | 0.24 | -0.01 | -8.19 | 0.69 | 1.19 |
| Average Basic Shares Outstanding | 79.52M | 78.86M | 43.93M | 16.45M | 13.70M |
| Average Diluted Shares Outstanding | 84.53M | 78.86M | 43.93M | 16.45M | 13.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |